{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T05:58:40Z","timestamp":1790488720331,"version":"4.1.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Malar J"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1475-2875-13-407","type":"journal-article","created":{"date-parts":[[2014,10,16]],"date-time":"2014-10-16T05:01:30Z","timestamp":1413435690000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Enantiomerically pure amino-alcohol quinolines: in vitro anti-malarial activity in combination with dihydroartemisinin, cytotoxicity and in vivo efficacy in a Plasmodium berghei mouse model"],"prefix":"10.1186","volume":"13","author":[{"given":"Catherine","family":"Mulli\u00e9","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Taudon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille","family":"Degrouas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexia","family":"Jonet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aur\u00e9lie","family":"Pascual","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrice","family":"Agnamey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Sonnet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,10,16]]},"reference":[{"key":"3565_CR1","volume-title":"World Malaria Report 2013","author":"WHO","year":"2013","unstructured":"WHO: World Malaria Report 2013. 2013, Geneva: World Health Organization"},{"key":"3565_CR2","unstructured":"Worldwide Antimalarial Resistance Network: Malaria Drug Resistance. \n                    http:\/\/www.wwarn.org\/resistance\/malaria\n                    \n                   (accessed July 15, 2014)"},{"key":"3565_CR3","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1056\/NEJMoa0808859","volume":"361","author":"AM Dondorp","year":"2009","unstructured":"Dondorp AM, Nosten F, Yi P, Das D, Phyo AP, Tarning J, Lwin KM, Ariey F, Hanpithakpong W, Lee SJ, Ringwald P, Silamut K, Imwong M, Chotivanich K, Lim P, Herdman T, An SS, Yeung S, Singhasivanon P, Day NP, Lindegardh N, Socheat D, White NJ: Artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med. 2009, 361: 455-467. 10.1056\/NEJMoa0808859.","journal-title":"N Engl J Med"},{"key":"3565_CR4","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/1475-2875-13-77","volume":"13","author":"VS Pribluda","year":"2014","unstructured":"Pribluda VS, Evans L, Barillas E, Marmion J, Lukulay P, Chang J: Were medicine quality and pharmaceutical management contributing factors in diminishing artemisinin efficacy in Guyana and Suriname?. Malar J. 2014, 13: 77-10.1186\/1475-2875-13-77.","journal-title":"Malar J"},{"key":"3565_CR5","volume-title":"Guidelines for The Treatment of Malaria","author":"WHO","year":"2006","unstructured":"WHO: Guidelines for The Treatment of Malaria. 2006, Geneva: World Health Organization"},{"key":"3565_CR6","volume-title":"Global Plan for Artemisinin Resistance Containment","author":"WHO","year":"2011","unstructured":"WHO: Global Plan for Artemisinin Resistance Containment. 2011, Geneva: World Health Organization"},{"key":"3565_CR7","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.2165\/00003088-200342150-00004","volume":"42","author":"DR Brocks","year":"2003","unstructured":"Brocks DR, Mehvar R: Stereoselectivity in the pharmacodynamics and pharmacokinetics of the chiral antimalarial drugs. Clin Pharmacokinet. 2003, 42: 1359-1382. 10.2165\/00003088-200342150-00004.","journal-title":"Clin Pharmacokinet"},{"key":"3565_CR8","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1093\/cid\/ciq249","volume":"52","author":"NM Douglas","year":"2011","unstructured":"Douglas NM, Nosten F, Ashley EA, Phaiphun L, van Vugt M, Singhasivanon P, White NJ, Price RN: Plasmodium vivax recurrence following falciparum and mixed species malaria: risk factors and effect of antimalarial kinetics. Clin Infect Dis. 2011, 52: 612-620. 10.1093\/cid\/ciq249.","journal-title":"Clin Infect Dis"},{"key":"3565_CR9","doi-asserted-by":"publisher","first-page":"25","DOI":"10.2165\/00002018-200427010-00003","volume":"27","author":"WR Taylor","year":"2004","unstructured":"Taylor WR, White NJ: Antimalarial drug toxicity: a review. Drug Saf. 2004, 27: 25-61.","journal-title":"Drug Saf"},{"key":"3565_CR10","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1186\/1475-2875-9-357","volume":"9","author":"P Schlagenhauf","year":"2010","unstructured":"Schlagenhauf P, Adamcova M, Regep L, Schaerer MT, Rhein HG: The position of mefloquine as a 21st century malaria chemoprophylaxis. Malar J. 2010, 9: 357-10.1186\/1475-2875-9-357.","journal-title":"Malar J"},{"key":"3565_CR11","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1006\/expr.1993.1042","volume":"76","author":"JM Karle","year":"1993","unstructured":"Karle JM, Olmeda R, Gerena L, Milhous WK: Plasmodium falciparum: role of absolute stereochemistry in the antimalarial activity of synthetic amino alcohol antimalarial agents. Exp Parasitol. 1993, 76: 345-351. 10.1006\/expr.1993.1042.","journal-title":"Exp Parasitol"},{"key":"3565_CR12","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1002\/cplu.201300074","volume":"7","author":"A Dassonville-Klimpt","year":"2013","unstructured":"Dassonville-Klimpt A, C\u00e9zard C, Mulli\u00e9 C, Agnamey P, Jonet A, Da Nascimento S, Marchivie M, Guillon J, Sonnet P: Absolute configuration and antimalarial activity of erythro-mefloquine enantiomers. ChemPlusChem. 2013, 7: 642-646.","journal-title":"ChemPlusChem"},{"key":"3565_CR13","volume-title":"Use of (+) Mefloquine for the Treatment of Malaria","author":"J Shepherd","year":"1998","unstructured":"Shepherd J: Use of (+) Mefloquine for the Treatment of Malaria. 1998, International patent WO98\/39003"},{"key":"3565_CR14","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.tetasy.2011.01.003","volume":"22","author":"A Jonet","year":"2011","unstructured":"Jonet A, Dassonville-Klimpt A, Da Nascimento S, L\u00e9ger JM, Guillon J, Sonnet P: First enantioselective synthesis of 4-aminoalcohol quinoline derivatives through a regioselective SN2 epoxide opening mechanism. Tetrahedron Asymmetry. 2011, 22: 138-148. 10.1016\/j.tetasy.2011.01.003.","journal-title":"Tetrahedron Asymmetry"},{"key":"3565_CR15","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/1475-2875-11-65","volume":"11","author":"C Mulli\u00e9","year":"2012","unstructured":"Mulli\u00e9 C, Jonet A, Desgrouas C, Taudon N, Sonnet P: Differences in anti-malarial activity of 4-aminoalcohol quinoline enantiomers and investigation of the presumed underlying mechanism of action. Malar J. 2012, 11: 65-10.1186\/1475-2875-11-65.","journal-title":"Malar J"},{"key":"3565_CR16","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1128\/AAC.16.6.710","volume":"16","author":"RE Desjardins","year":"1979","unstructured":"Desjardins RE, Canfield CJ, Haynes JD, Chulay JD: Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique. Antimicrob Agents Chemother. 1979, 16: 710-718. 10.1128\/AAC.16.6.710.","journal-title":"Antimicrob Agents Chemother"},{"key":"3565_CR17","doi-asserted-by":"publisher","first-page":"418","DOI":"10.2307\/3280287","volume":"65","author":"C Lambros","year":"1979","unstructured":"Lambros C, Vanderberg JP: Synchronization of Plasmodium falciparum erythrocytic stages in culture. J Parasitol. 1979, 65: 418-420. 10.2307\/3280287.","journal-title":"J Parasitol"},{"key":"3565_CR18","doi-asserted-by":"publisher","first-page":"4097","DOI":"10.1128\/AAC.48.11.4097-4102.2004","volume":"48","author":"QL Fivelman","year":"2004","unstructured":"Fivelman QL, Adagu IS, Warhurst DC: Modified fixed-ratio isobologram method for studying in vitro interactions between atovaquone and proguanil or dihydroartemisinin against drug-resistant strains of Plasmodium falciparum. Antimicrob Agents Chemother. 2004, 48: 4097-4102. 10.1128\/AAC.48.11.4097-4102.2004.","journal-title":"Antimicrob Agents Chemother"},{"key":"3565_CR19","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1093\/infdis\/137.2.122","volume":"137","author":"MC Berenbaum","year":"1978","unstructured":"Berenbaum MC: A method for testing synergy with any number of agents. J Infect Dis. 1978, 137: 122-130. 10.1093\/infdis\/137.2.122.","journal-title":"J Infect Dis"},{"key":"3565_CR20","unstructured":"R Develoment Core Team: R: A Language and Environment for Statistical Computing. \n                    http:\/\/r-project.org\n                    \n                   (accessed November 2013)"},{"key":"3565_CR21","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1093\/infdis\/jir033","volume":"203","author":"AD Douglas","year":"2011","unstructured":"Douglas AD, Andrews L, Draper SJ, Bojang K, Milligan P, Gilbert SC, Imoukhuede EB, Hill AV: Substantially reduced pre-patent parasite multiplication rates are associated with naturally acquired immunity to Plasmodium falciparum. J Infect Dis. 2011, 203: 1337-1340. 10.1093\/infdis\/jir033.","journal-title":"J Infect Dis"},{"key":"3565_CR22","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4899-3115-3","volume-title":"Modelling Survival Data in Medical Research","author":"D Collett","year":"1994","unstructured":"Collett D: Modelling Survival Data in Medical Research. 1994"},{"key":"3565_CR23","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S0041-0101(03)00097-7","volume":"42","author":"S Taniyama","year":"2003","unstructured":"Taniyama S, Arakawa O, Terada M, Nishio S, Takatani T, Mahmud Y, Noguchi T: Ostreopsis sp., a possible origin of palytoxin (PTX) in parrotfish Scarus ovifrons. Toxicon. 2003, 42: 29-33. 10.1016\/S0041-0101(03)00097-7.","journal-title":"Toxicon"},{"key":"3565_CR24","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1128\/AAC.46.5.1510-1515.2002","volume":"46","author":"S Gupta","year":"2002","unstructured":"Gupta S, Thapar MM, Wernsdorfer WH, Bj\u00f6rkman A: In vitro interactions of artemisinin with atovaquone, quinine, and mefloquine against Plasmodium falciparum. Antimicrob Agents Chemother. 2002, 46: 1510-1515. 10.1128\/AAC.46.5.1510-1515.2002.","journal-title":"Antimicrob Agents Chemother"},{"issue":"Suppl 3","key":"3565_CR25","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s00508-010-1439-5","volume":"122","author":"G Kerschbaumer","year":"2010","unstructured":"Kerschbaumer G, Wernsdorfer G, Wiedermann U, Congpuong K, Sirichaisinthop J, Wernsdorfer WH: Synergism between mefloquine and artemisinin and its enhancement by retinol in Plasmodium falciparum in vitro. Wien Klin Wochenschr. 2010, 122 (Suppl 3): 57-60.","journal-title":"Wien Klin Wochenschr"},{"key":"3565_CR26","doi-asserted-by":"publisher","first-page":"979","DOI":"10.4269\/ajtmh.2009.09-0394","volume":"81","author":"A Sowunmi","year":"2009","unstructured":"Sowunmi A, Gbotosho GO, Happi C, Okuboyejo T, Folarin O, Balogun S, Michael O: Therapeutic efficacy and effects of artesunate-mefloquine and mefloquine alone on malaria-associated anemia in children with uncomplicated Plasmodium falciparum malaria in southwest Nigeria. Am J Trop Med Hyg. 2009, 81: 979-986. 10.4269\/ajtmh.2009.09-0394.","journal-title":"Am J Trop Med Hyg"},{"key":"3565_CR27","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.1086\/315141","volume":"180","author":"C Cerutti Jr","year":"1999","unstructured":"Cerutti C, Durlacher RR, de Alencar FE, Segurado AA, Pang LW: In vivo efficacy of mefloquine for the treatment of Falciparum malaria in Brazil. J Infect Dis. 1999, 180: 2077-2080. 10.1086\/315141.","journal-title":"J Infect Dis"},{"key":"3565_CR28","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1038\/ja.2013.71","volume":"66","author":"A Jonet","year":"2013","unstructured":"Jonet A, Dassonville-Klimpt A, Sonnet P, Mulli\u00e9 C: Side chain length is more important than stereochemistry in the antibacterial activity of enantiomerically pure 4-aminoalcohol quinoline derivatives. J Antibiot (Tokyo). 2013, 66: 683-686. 10.1038\/ja.2013.71.","journal-title":"J Antibiot (Tokyo)"}],"container-title":["Malaria Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1475-2875-13-407.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,22]],"date-time":"2019-01-22T01:27:13Z","timestamp":1548120433000},"score":1,"resource":{"primary":{"URL":"https:\/\/malariajournal.biomedcentral.com\/articles\/10.1186\/1475-2875-13-407"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10,16]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["3565"],"URL":"https:\/\/doi.org\/10.1186\/1475-2875-13-407","relation":{},"ISSN":["1475-2875"],"issn-type":[{"value":"1475-2875","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,10,16]]},"assertion":[{"value":"31 July 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"407"}}